Synopsis
0
USDMF
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
39
PharmaCompass offers a list of Felypressin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Felypressin manufacturer or Felypressin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Felypressin manufacturer or Felypressin supplier.
PharmaCompass also assists you with knowing the Felypressin API Price utilized in the formulation of products. Felypressin API Price is not always fixed or binding as the Felypressin Price is obtained through a variety of data sources. The Felypressin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Octapressin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Octapressin, including repackagers and relabelers. The FDA regulates Octapressin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Octapressin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Octapressin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Octapressin supplier is an individual or a company that provides Octapressin active pharmaceutical ingredient (API) or Octapressin finished formulations upon request. The Octapressin suppliers may include Octapressin API manufacturers, exporters, distributors and traders.
click here to find a list of Octapressin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Octapressin Drug Master File in Japan (Octapressin JDMF) empowers Octapressin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Octapressin JDMF during the approval evaluation for pharmaceutical products. At the time of Octapressin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Octapressin suppliers with JDMF on PharmaCompass.
A Octapressin CEP of the European Pharmacopoeia monograph is often referred to as a Octapressin Certificate of Suitability (COS). The purpose of a Octapressin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Octapressin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Octapressin to their clients by showing that a Octapressin CEP has been issued for it. The manufacturer submits a Octapressin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Octapressin CEP holder for the record. Additionally, the data presented in the Octapressin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Octapressin DMF.
A Octapressin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Octapressin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Octapressin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Octapressin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Octapressin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Octapressin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Octapressin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Octapressin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Octapressin suppliers with NDC on PharmaCompass.
Octapressin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Octapressin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Octapressin GMP manufacturer or Octapressin GMP API supplier for your needs.
A Octapressin CoA (Certificate of Analysis) is a formal document that attests to Octapressin's compliance with Octapressin specifications and serves as a tool for batch-level quality control.
Octapressin CoA mostly includes findings from lab analyses of a specific batch. For each Octapressin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Octapressin may be tested according to a variety of international standards, such as European Pharmacopoeia (Octapressin EP), Octapressin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Octapressin USP).
